ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,175, issued on Sept. 30, was assigned to The Chinese University of Hong Kong (Hong Kong).

"Fecal fungome and therapeutic efficacy of fecal microbiota transplantation" was invented by Siew Chien Ng (Hong Kong), Tao Zuo (Qingzhou, China) and Ka Leung Francis Chan (Hong Kong).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention resides in the discovery that altered abundance of fungal species in the gut and feces of both fecal microbiota transplantation (FMT) donors and recipients may influence the outcome of FMT treatment. Thus, novel methods are provided for identifying subjects as suitable donor or recipients for FMT, for assessing t...